Ocular pharmacokinetics of dapiprazole

Area of Science:

• Ophthalmology
• Pharmacology
• Adrenergic Receptor Research

Background:

• Dapiprazole is an alpha 1 adrenergic antagonist.
• Topical ocular drug delivery presents challenges in achieving therapeutic concentrations within specific eye tissues.

Purpose of the Study:

• To investigate the ocular pharmacokinetics and pharmacodynamics of topically administered Dapiprazole.
• To determine the affinity of Dapiprazole for ocular structures containing alpha-adrenergic receptors.

Main Methods:

• Topical ocular instillation of Dapiprazole in a relevant model.
• Measurement of drug concentrations in ocular tissues (ciliary bodies, iris, aqueous humor) and plasma.
• Assessment of miotic and hypotensive effects.

Main Results:

• Dapiprazole rapidly penetrates the corneal epithelium, achieving high concentrations in ocular tissues.
• A significant concentration gradient was observed between ciliary bodies/iris and aqueous humor, suggesting specific tissue affinity.
• Minimal Dapiprazole concentrations were detected in plasma and the contralateral eye, indicating negligible systemic absorption.

Conclusions:

• Topical Dapiprazole demonstrates efficient ocular penetration and localized action.
• The drug exhibits a specific affinity for ocular tissues rich in alpha-adrenergic receptors.
• Negligible systemic absorption supports the safety profile of topical Dapiprazole for ophthalmic use.